APAC受託製造市場 - 産業動向と2030年までの予測APAC Contract Manufacturing Market - Industry Trends and Forecast to 2030 アジア太平洋地域の受託製造市場は、2023年から2030年の予測期間において5.8%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、... もっと見る
サマリーアジア太平洋地域の受託製造市場は、2023年から2030年の予測期間において5.8%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、予測期間は2023年から2030年です市場セグメンテーション アジア太平洋地域の受託製造市場、製品別(医療機器製造、医薬品製造)、エンドユーザー別(相手先ブランド製造会社、医療機器会社、製薬会社、バイオテクノロジー会社、バイオ医薬品会社、研究機関)、流通チャネル(直接入札、小売販売、その他)、国(中国、日本、インド、韓国、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピン、その他アジア太平洋) 産業動向および2030年までの予測 アジア太平洋地域の受託製造市場の成長に寄与する主な要因としては、以下のようなものが挙げられます: - ヘルスケア分野における技術的進歩の拡大 - 費用対効果の向上とキープレイヤーのグローバルなプレゼンス 市場のプレイヤー: アジア太平洋地域の受託製造市場で活動している主なプレイヤーは以下の通りです: - アエノバグループ - サーモフィッシャーサイエンティフィック社(Thermo Fisher Scientific, Inc. - エボニック・インダストリーズ・アグ - ロンザ - ベーリンガーインゲルハイムバイオファーマシューティカルズGmbH. - キャタレント社 - サンファーマシューティカルインダストリー株式会社 - ニプロファーマ株式会社 - ファイザー株式会社(Pfizer Inc. - レシファームAB - ヴェター - TEコネクティビティ - メルクKGaA - アルマックグループ - ジークフリードホールディングAG - ジュビラント・ファーマ・リミテッド - アビッドバイオサービシーズ株式会社 - バクスター - キンブルエレクトロニクス株式会社 - ファマーヘルスケアサービス - アッヴィー社(AbbVie Inc. 目次TABLE OF CONTENTS1 INTRODUCTION 42 1.1 OBJECTIVES OF THE STUDY 42 1.2 MARKET DEFINITION 42 1.3 OVERVIEW OF THE ASIA PACIFIC CONTRACT MANUFACTURING MARKET 42 1.4 CURRENCY AND PRICING 44 1.5 LIMITATIONS 44 1.6 MARKETS COVERED 44 2 MARKET SEGMENTATION 47 2.1 MARKETS COVERED 47 2.2 GEOGRAPHICAL SCOPE 48 2.3 YEARS CONSIDERED FOR THE STUDY 49 2.4 DBMR TRIPOD DATA VALIDATION MODEL 50 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53 2.6 MULTIVARIATE MODELLING 54 2.7 PRODUCT SEGMENT LIFELINE CURVE 54 2.8 MARKET END USER COVERAGE GRID 55 2.9 DBMR MARKET POSITION GRID 56 2.10 VENDOR SHARE ANALYSIS 57 2.11 SECONDARY SOURCES 58 2.12 ASSUMPTIONS 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 61 4.1 PESTEL ANALYSIS 62 4.2 PORTER'S FIVE FORCES 63 4.3 STRATEGIC INITIATIVES: 64 5 REGULATORY FRAMEWORK 65 5.1 REGULATORY SCENARIO BY FDA 65 5.2 REGULATORY SCENARIO IN AUSTRALIA 66 5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 67 6 MARKET OVERVIEW 68 6.1 DRIVERS 70 6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 70 6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 70 6.1.3 ASIA PACIFIC PRESENCE AND CONNECTED NETWORK 71 6.2 RESTRAINTS 71 6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 71 6.2.2 RISK OF CONFIDENTIAL INFORMATION 72 6.3 OPPORTUNITIES 72 6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 72 6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 73 6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73 6.4 CHALLENGES 74 6.4.1 INTELLECTUAL PROPERTY RISKS 74 6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 74 7 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT 75 7.1 OVERVIEW 76 7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 79 7.2.1 TYPES OF PRODUCTS 80 7.2.1.1 TABLETS 80 7.2.1.2 CAPSULES 80 7.2.1.3 BIOLOGICS 81 7.2.1.4 SMALL MOLECULE 81 7.2.1.5 CELL & GENES MANUFACTURING 81 7.2.1.6 NUTRACEUTICALS 81 7.2.1.7 OTHERS 81 7.2.2 TYPE OF SERVICES 81 7.2.2.1 DRUG DEVELOPMENT SERVICES 82 7.2.2.2 TABLET MANUFACTURING SERVICES 82 7.2.2.3 BIOLOGICS API MANUFACTURING 82 7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 82 7.2.2.5 OTHERS 82 7.2.3 BY DOSAGE FORM 82 7.2.3.1 SOLID FORMULATIONS 83 7.2.3.2 LIQUID FORMULATIONS 83 7.2.3.2.1 INJECTABLE 83 7.2.3.2.2 SYRUPS 83 7.2.3.3 SEMI-SOLID FORMULATIONS 83 7.2.3.4 TOPICAL DRUG FORMULATIONS 83 7.2.3.5 OTHERS 83 7.3 MEDICAL DEVICE MANUFACTURING 84 7.3.1 TYPE OF DEVICES 85 7.3.1.1 SYRINGES AND NEEDLES 86 7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 86 7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 86 7.3.1.4 DISPOSABLES 86 7.3.1.5 IVD DEVICES 87 7.3.1.6 CARDIOVASCULAR DEVICES 87 7.3.1.7 DIABETES CARE DEVICES 87 7.3.1.8 GENERAL SURGERY DEVICES 87 7.3.1.9 ORTHOPEDIC DEVICES 87 7.3.1.10 RESPIRATORY DEVICES 87 7.3.1.11 OPHTHALMIC DEVICES 87 7.3.1.12 DENTAL DEVICES 87 7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 87 7.3.1.14 LABORATORY EQUIPMENT 87 7.3.2 TYPE OF SERVICES 88 7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 88 7.3.2.2 DEVICE ASSEMBLY 88 7.3.2.3 REGULATORY ASSISTANCE 88 7.3.2.4 PACKAGING & LABELLING 88 7.3.2.5 STERILIZATION SERVICES 89 7.3.2.6 TRAINING AND VALIDATION 89 7.3.2.7 QUALITY ASSURANCE 89 7.3.2.8 OTHERS 89 7.3.3 BY DEVICE CLASS 89 7.3.3.1 CLASS I MEDICAL DEVICES 90 7.3.3.2 CLASS IIA MEDICAL DEVICES 90 7.3.3.3 CLASS IIB MEDICAL DEVICES 90 7.3.3.4 CLASS III MEDICAL DEVICES 90 8 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER 91 8.1 OVERVIEW 92 8.2 PHARMACEUTICAL COMPANIES 95 8.3 BIOTECHNOLOGY COMPANIES 95 8.4 BIOPHARMA COMPANIES 96 8.5 MEDICAL DEVICES COMPANIES 97 8.6 ORIGINAL EQUIPMENT MANUFACTURER 97 8.7 RESEARCH INSTITUTES 98 9 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 99 9.1 OVERVIEW 100 9.2 RETAIL SALES 103 9.3 DIRECT TENDER 104 9.4 OTHERS 105 10 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY REGION 106 10.1 ASIA PACIFIC 107 10.1.1 JAPAN 120 10.1.2 CHINA 128 10.1.3 SOUTH KOREA 136 10.1.4 INDIA 143 10.1.5 AUSTRALIA 151 10.1.6 SINGAPORE 159 10.1.7 THAILAND 167 10.1.8 MALAYSIA 175 10.1.9 INDONESIA 183 10.1.10 PHILIPPINES 191 10.1.11 REST OF ASIA-PACIFIC 199 11 ASIA PACIFIC CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 200 11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 200 12 SWOT ANALYSIS 201 13 COMPANY PROFILE 202 13.1 AENOVA GROUP 202 13.1.1 COMPANY SNAPSHOT 202 13.1.2 COMPANY SHARE ANALYSIS 202 13.1.3 PRODUCT PORTFOLIO 203 13.1.4 RECENT DEVELOPMENTS 203 13.2 THERMO FISHER SCIENTIFIC INC. 204 13.2.1 COMPANY SNAPSHOT 204 13.2.2 REVENUE ANALYSIS 205 13.2.3 COMPANY SHARE ANALYSIS 205 13.2.4 PRODUCT PORTFOLIO 206 13.2.5 RECENT DEVELOPMENTS 206 13.3 EVONIK INDUSTRIES AG 207 13.3.1 COMPANY SNAPSHOT 207 13.3.2 REVENUE ANALYSIS 207 13.3.3 COMPANY SHARE ANALYSIS 208 13.3.4 PRODUCT PORTFOLIO 208 13.3.5 RECENT DEVELOPMENTS 208 13.4 LONZA 209 13.4.1 COMPANY SNAPSHOT 209 13.4.2 REVENUE ANALYSIS 209 13.4.3 COMPANY SHARE ANALYSIS 210 13.4.4 PRODUCT PORTFOLIO 210 13.4.5 RECENT DEVELOPMENTS 211 13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 212 13.5.1 COMPANY SNAPSHOT 212 13.5.2 REVENUE ANALYSIS 212 13.5.3 COMPANY SHARE ANALYSIS 213 13.5.4 PRODUCT PORTFOLIO 213 13.5.5 RECENT DEVELOPMENTS 213 13.6 ABBVIE INC. 214 13.6.1 COMPANY SNAPSHOT 214 13.6.2 REVENUE ANALYSIS 214 13.6.3 PRODUCT PORTFOLIO 215 13.6.4 RECENT DEVELOPMENT 215 13.7 ALMAC GROUP 216 13.7.1 COMPANY SNAPSHOT 216 13.7.2 PRODUCT PORTFOLIO 216 13.7.3 RECENT DEVELOPMENTS 216 13.8 AVID BIOSERVICES, INC. 217 13.8.1 COMPANY SNAPSHOT 217 13.8.2 REVENUE ANALYSIS 217 13.8.3 PRODUCT PORTFOLIO 218 13.8.4 RECENT DEVELOPMENT 218 13.9 BAXTER 219 13.9.1 COMPANY SNAPSHOT 219 13.9.2 REVENUE ANALYSIS 219 13.9.3 PRODUCT PORTFOLIO 220 13.9.4 RECENT DEVELOPMENTS 221 13.10 CATALENT, INC 222 13.10.1 COMPANY SNAPSHOT 222 13.10.2 REVENUE ANALYSIS 222 13.10.3 PRODUCT PORTFOLIO 223 13.10.4 RECENT DEVELOPMENT 223 13.11 FAMAR HEALTH CARE SERVICES 224 13.11.1 COMPANY SNAPSHOT 224 13.11.2 PRODUCT PORTFOLIO 224 13.11.3 RECENT DEVELOPMENTS 224 13.12 JUBILANT PHARMA LIMITED 225 13.12.1 COMPANY SNAPSHOT 225 13.12.2 REVENUE ANALYSIS 225 13.12.3 PRODUCT PORTFOLIO 226 13.12.4 RECENT DEVELOPMENT 226 13.13 KIMBALL INTERNATIONAL 227 13.13.1 COMPANY SNAPSHOT 227 13.13.2 REVENUE ANALYSIS 227 13.13.3 PRODUCT PORTFOLIO 228 13.13.4 RECENT DEVELOPMENT 228 13.14 MERCK KGAA 229 13.14.1 COMPANY SNAPSHOT 229 13.14.2 REVENUE ANALYSIS 229 13.14.3 PRODUCT PORTFOLIO 230 13.14.4 RECENT DEVELOPMENTS 230 13.15 NIPR0 231 13.15.1 COMPANY SNAPSHOT 231 13.15.2 REVENUE ANALYSIS 231 13.15.3 PRODUCT PORTFOLIO 232 13.15.4 RECENT DEVELOPMENT 232 13.16 PFIZER INC 233 13.16.1 COMPANY SNAPSHOT 233 13.16.2 REVENUE ANALYSIS 233 13.16.3 PRODUCT PORTFOLIO 234 13.16.4 RECENT DEVELOPMENT 234 13.17 RECIPHARM AB. 235 13.17.1 COMPANY SNAPSHOT 235 13.17.2 REVENUE ANALYSIS 235 13.17.3 PRODUCT PORTFOLIO 236 13.17.4 RECENT DEVELOPMENT 236 13.18 SIEGFRIED HOLDING AG 237 13.18.1 COMPANY SNAPSHOT 237 13.18.2 REVENUE ANALYSIS 237 13.18.3 PRODUCT PORTFOLIO 238 13.18.4 RECENT DEVELOPMENTS 238 13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 239 13.19.1 COMPANY SNAPSHOT 239 13.19.2 REVENUE ANALYSIS 239 13.19.3 PRODUCT PORTFOLIO 240 13.19.4 RECENT DEVELOPMENT 240 13.20 TE CONNECTIVITY 241 13.20.1 COMPANY SNAPSHOT 241 13.20.2 REVENUE ANALYSIS 241 13.20.3 PRODUCT PORTFOLIO 242 13.20.4 RECENT DEVELOPMENT 242 13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 243 13.21.1 COMPANY SNAPSHOT 243 13.21.2 PRODUCT PORTFOLIO 243 13.21.3 RECENT DEVELOPMENTS 243 14 QUESTIONNAIRE 244 15 RELATED REPORTS 247 図表リストLIST OF TABLESTABLE 1 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59 TABLE 2 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 60 TABLE 3 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61 TABLE 4 ASIA PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61 TABLE 5 ASIA PACIFIC BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62 TABLE 6 ASIA PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 63 TABLE 7 ASIA PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64 TABLE 8 ASIA PACIFIC MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 65 TABLE 9 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 66 TABLE 10 ASIA PACIFIC TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67 TABLE 11 ASIA PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 69 TABLE 12 ASIA PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 70 TABLE 13 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 75 TABLE 14 ASIA PACIFIC PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76 TABLE 15 ASIA PACIFIC BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77 TABLE 16 ASIA PACIFIC BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77 TABLE 17 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 78 TABLE 18 ASIA PACIFIC ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79 TABLE 19 ASIA PACIFIC RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79 TABLE 20 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 83 TABLE 21 ASIA PACIFIC RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84 TABLE 22 ASIA PACIFIC DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 85 TABLE 23 ASIA PACIFIC OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 86 TABLE 24 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 92 TABLE 25 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92 TABLE 26 ASIA-PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93 TABLE 27 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93 TABLE 28 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT) 94 TABLE 29 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP) 94 TABLE 30 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 31 ASIA-PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 32 ASIA-PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 33 ASIA-PACIFIC MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96 TABLE 34 ASIA-PACIFIC TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96 TABLE 35 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 97 TABLE 36 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 98 TABLE 37 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99 TABLE 38 ASIA-PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99 TABLE 39 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 100 TABLE 40 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100 TABLE 41 JAPAN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 42 JAPAN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 43 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 44 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 102 TABLE 45 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 102 TABLE 46 JAPAN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 47 JAPAN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 48 JAPAN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 49 JAPAN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104 TABLE 50 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104 TABLE 51 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 105 TABLE 52 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 106 TABLE 53 JAPAN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107 TABLE 54 JAPAN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107 TABLE 55 JAPAN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 108 TABLE 56 JAPAN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108 TABLE 57 CHINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 58 CHINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 59 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 60 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 110 TABLE 61 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 110 TABLE 62 CHINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 63 CHINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 64 CHINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 65 CHINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112 TABLE 66 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112 TABLE 67 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 113 TABLE 68 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 114 TABLE 69 CHINA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115 TABLE 70 CHINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115 TABLE 71 CHINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 116 TABLE 72 CHINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 116 TABLE 73 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 74 SOUTH KOREA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 75 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 76 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 118 TABLE 77 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 118 TABLE 78 SOUTH KOREA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 79 SOUTH KOREA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 80 SOUTH KOREA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 81 SOUTH KOREA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120 TABLE 82 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120 TABLE 83 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 121 TABLE 84 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 122 TABLE 85 SOUTH KOREA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 122 TABLE 86 SOUTH KOREA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123 TABLE 87 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 123 TABLE 88 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 123 TABLE 89 INDIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 90 INDIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 91 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 92 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 125 TABLE 93 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 125 TABLE 94 INDIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 95 INDIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 96 INDIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 97 INDIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127 TABLE 98 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127 TABLE 99 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 128 TABLE 100 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 129 TABLE 101 INDIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130 TABLE 102 INDIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130 TABLE 103 INDIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 131 TABLE 104 INDIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131 TABLE 105 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 106 AUSTRALIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 107 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 108 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 133 TABLE 109 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 133 TABLE 110 AUSTRALIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 111 AUSTRALIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 112 AUSTRALIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 113 AUSTRALIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135 TABLE 114 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135 TABLE 115 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 136 TABLE 116 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 137 TABLE 117 AUSTRALIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138 TABLE 118 AUSTRALIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138 TABLE 119 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 139 TABLE 120 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139 TABLE 121 SINGAPORE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 122 SINGAPORE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 123 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 124 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 141 TABLE 125 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 141 TABLE 126 SINGAPORE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 127 SINGAPORE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 128 SINGAPORE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 129 SINGAPORE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143 TABLE 130 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143 TABLE 131 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 144 TABLE 132 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 145 TABLE 133 SINGAPORE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146 TABLE 134 SINGAPORE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146 TABLE 135 SINGAPORE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 147 TABLE 136 SINGAPORE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147 TABLE 137 THAILAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 138 THAILAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 139 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 140 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 149 TABLE 141 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 149 TABLE 142 THAILAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 143 THAILAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 144 THAILAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 145 THAILAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151 TABLE 146 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151 TABLE 147 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 152 TABLE 148 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 153 TABLE 149 THAILAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154 TABLE 150 THAILAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154 TABLE 151 THAILAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 155 TABLE 152 THAILAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 155 TABLE 153 MALAYSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 154 MALAYSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 155 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 156 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 157 TABLE 157 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 157 TABLE 158 MALAYSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 159 MALAYSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 160 MALAYSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 161 MALAYSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159 TABLE 162 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159 TABLE 163 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 160 TABLE 164 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 161 TABLE 165 MALAYSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162 TABLE 166 MALAYSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162 TABLE 167 MALAYSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 163 TABLE 168 MALAYSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163 TABLE 169 INDONESIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 170 INDONESIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 171 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 172 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 165 TABLE 173 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 165
SummaryThe Asia-Pacific contract manufacturing market is projected to register a substantial CAGR of 5.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030 Table of ContentsTABLE OF CONTENTS1 INTRODUCTION 42 1.1 OBJECTIVES OF THE STUDY 42 1.2 MARKET DEFINITION 42 1.3 OVERVIEW OF THE ASIA PACIFIC CONTRACT MANUFACTURING MARKET 42 1.4 CURRENCY AND PRICING 44 1.5 LIMITATIONS 44 1.6 MARKETS COVERED 44 2 MARKET SEGMENTATION 47 2.1 MARKETS COVERED 47 2.2 GEOGRAPHICAL SCOPE 48 2.3 YEARS CONSIDERED FOR THE STUDY 49 2.4 DBMR TRIPOD DATA VALIDATION MODEL 50 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53 2.6 MULTIVARIATE MODELLING 54 2.7 PRODUCT SEGMENT LIFELINE CURVE 54 2.8 MARKET END USER COVERAGE GRID 55 2.9 DBMR MARKET POSITION GRID 56 2.10 VENDOR SHARE ANALYSIS 57 2.11 SECONDARY SOURCES 58 2.12 ASSUMPTIONS 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 61 4.1 PESTEL ANALYSIS 62 4.2 PORTER'S FIVE FORCES 63 4.3 STRATEGIC INITIATIVES: 64 5 REGULATORY FRAMEWORK 65 5.1 REGULATORY SCENARIO BY FDA 65 5.2 REGULATORY SCENARIO IN AUSTRALIA 66 5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 67 6 MARKET OVERVIEW 68 6.1 DRIVERS 70 6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 70 6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 70 6.1.3 ASIA PACIFIC PRESENCE AND CONNECTED NETWORK 71 6.2 RESTRAINTS 71 6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 71 6.2.2 RISK OF CONFIDENTIAL INFORMATION 72 6.3 OPPORTUNITIES 72 6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 72 6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 73 6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73 6.4 CHALLENGES 74 6.4.1 INTELLECTUAL PROPERTY RISKS 74 6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 74 7 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT 75 7.1 OVERVIEW 76 7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 79 7.2.1 TYPES OF PRODUCTS 80 7.2.1.1 TABLETS 80 7.2.1.2 CAPSULES 80 7.2.1.3 BIOLOGICS 81 7.2.1.4 SMALL MOLECULE 81 7.2.1.5 CELL & GENES MANUFACTURING 81 7.2.1.6 NUTRACEUTICALS 81 7.2.1.7 OTHERS 81 7.2.2 TYPE OF SERVICES 81 7.2.2.1 DRUG DEVELOPMENT SERVICES 82 7.2.2.2 TABLET MANUFACTURING SERVICES 82 7.2.2.3 BIOLOGICS API MANUFACTURING 82 7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 82 7.2.2.5 OTHERS 82 7.2.3 BY DOSAGE FORM 82 7.2.3.1 SOLID FORMULATIONS 83 7.2.3.2 LIQUID FORMULATIONS 83 7.2.3.2.1 INJECTABLE 83 7.2.3.2.2 SYRUPS 83 7.2.3.3 SEMI-SOLID FORMULATIONS 83 7.2.3.4 TOPICAL DRUG FORMULATIONS 83 7.2.3.5 OTHERS 83 7.3 MEDICAL DEVICE MANUFACTURING 84 7.3.1 TYPE OF DEVICES 85 7.3.1.1 SYRINGES AND NEEDLES 86 7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 86 7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 86 7.3.1.4 DISPOSABLES 86 7.3.1.5 IVD DEVICES 87 7.3.1.6 CARDIOVASCULAR DEVICES 87 7.3.1.7 DIABETES CARE DEVICES 87 7.3.1.8 GENERAL SURGERY DEVICES 87 7.3.1.9 ORTHOPEDIC DEVICES 87 7.3.1.10 RESPIRATORY DEVICES 87 7.3.1.11 OPHTHALMIC DEVICES 87 7.3.1.12 DENTAL DEVICES 87 7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 87 7.3.1.14 LABORATORY EQUIPMENT 87 7.3.2 TYPE OF SERVICES 88 7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 88 7.3.2.2 DEVICE ASSEMBLY 88 7.3.2.3 REGULATORY ASSISTANCE 88 7.3.2.4 PACKAGING & LABELLING 88 7.3.2.5 STERILIZATION SERVICES 89 7.3.2.6 TRAINING AND VALIDATION 89 7.3.2.7 QUALITY ASSURANCE 89 7.3.2.8 OTHERS 89 7.3.3 BY DEVICE CLASS 89 7.3.3.1 CLASS I MEDICAL DEVICES 90 7.3.3.2 CLASS IIA MEDICAL DEVICES 90 7.3.3.3 CLASS IIB MEDICAL DEVICES 90 7.3.3.4 CLASS III MEDICAL DEVICES 90 8 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER 91 8.1 OVERVIEW 92 8.2 PHARMACEUTICAL COMPANIES 95 8.3 BIOTECHNOLOGY COMPANIES 95 8.4 BIOPHARMA COMPANIES 96 8.5 MEDICAL DEVICES COMPANIES 97 8.6 ORIGINAL EQUIPMENT MANUFACTURER 97 8.7 RESEARCH INSTITUTES 98 9 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 99 9.1 OVERVIEW 100 9.2 RETAIL SALES 103 9.3 DIRECT TENDER 104 9.4 OTHERS 105 10 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY REGION 106 10.1 ASIA PACIFIC 107 10.1.1 JAPAN 120 10.1.2 CHINA 128 10.1.3 SOUTH KOREA 136 10.1.4 INDIA 143 10.1.5 AUSTRALIA 151 10.1.6 SINGAPORE 159 10.1.7 THAILAND 167 10.1.8 MALAYSIA 175 10.1.9 INDONESIA 183 10.1.10 PHILIPPINES 191 10.1.11 REST OF ASIA-PACIFIC 199 11 ASIA PACIFIC CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 200 11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 200 12 SWOT ANALYSIS 201 13 COMPANY PROFILE 202 13.1 AENOVA GROUP 202 13.1.1 COMPANY SNAPSHOT 202 13.1.2 COMPANY SHARE ANALYSIS 202 13.1.3 PRODUCT PORTFOLIO 203 13.1.4 RECENT DEVELOPMENTS 203 13.2 THERMO FISHER SCIENTIFIC INC. 204 13.2.1 COMPANY SNAPSHOT 204 13.2.2 REVENUE ANALYSIS 205 13.2.3 COMPANY SHARE ANALYSIS 205 13.2.4 PRODUCT PORTFOLIO 206 13.2.5 RECENT DEVELOPMENTS 206 13.3 EVONIK INDUSTRIES AG 207 13.3.1 COMPANY SNAPSHOT 207 13.3.2 REVENUE ANALYSIS 207 13.3.3 COMPANY SHARE ANALYSIS 208 13.3.4 PRODUCT PORTFOLIO 208 13.3.5 RECENT DEVELOPMENTS 208 13.4 LONZA 209 13.4.1 COMPANY SNAPSHOT 209 13.4.2 REVENUE ANALYSIS 209 13.4.3 COMPANY SHARE ANALYSIS 210 13.4.4 PRODUCT PORTFOLIO 210 13.4.5 RECENT DEVELOPMENTS 211 13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 212 13.5.1 COMPANY SNAPSHOT 212 13.5.2 REVENUE ANALYSIS 212 13.5.3 COMPANY SHARE ANALYSIS 213 13.5.4 PRODUCT PORTFOLIO 213 13.5.5 RECENT DEVELOPMENTS 213 13.6 ABBVIE INC. 214 13.6.1 COMPANY SNAPSHOT 214 13.6.2 REVENUE ANALYSIS 214 13.6.3 PRODUCT PORTFOLIO 215 13.6.4 RECENT DEVELOPMENT 215 13.7 ALMAC GROUP 216 13.7.1 COMPANY SNAPSHOT 216 13.7.2 PRODUCT PORTFOLIO 216 13.7.3 RECENT DEVELOPMENTS 216 13.8 AVID BIOSERVICES, INC. 217 13.8.1 COMPANY SNAPSHOT 217 13.8.2 REVENUE ANALYSIS 217 13.8.3 PRODUCT PORTFOLIO 218 13.8.4 RECENT DEVELOPMENT 218 13.9 BAXTER 219 13.9.1 COMPANY SNAPSHOT 219 13.9.2 REVENUE ANALYSIS 219 13.9.3 PRODUCT PORTFOLIO 220 13.9.4 RECENT DEVELOPMENTS 221 13.10 CATALENT, INC 222 13.10.1 COMPANY SNAPSHOT 222 13.10.2 REVENUE ANALYSIS 222 13.10.3 PRODUCT PORTFOLIO 223 13.10.4 RECENT DEVELOPMENT 223 13.11 FAMAR HEALTH CARE SERVICES 224 13.11.1 COMPANY SNAPSHOT 224 13.11.2 PRODUCT PORTFOLIO 224 13.11.3 RECENT DEVELOPMENTS 224 13.12 JUBILANT PHARMA LIMITED 225 13.12.1 COMPANY SNAPSHOT 225 13.12.2 REVENUE ANALYSIS 225 13.12.3 PRODUCT PORTFOLIO 226 13.12.4 RECENT DEVELOPMENT 226 13.13 KIMBALL INTERNATIONAL 227 13.13.1 COMPANY SNAPSHOT 227 13.13.2 REVENUE ANALYSIS 227 13.13.3 PRODUCT PORTFOLIO 228 13.13.4 RECENT DEVELOPMENT 228 13.14 MERCK KGAA 229 13.14.1 COMPANY SNAPSHOT 229 13.14.2 REVENUE ANALYSIS 229 13.14.3 PRODUCT PORTFOLIO 230 13.14.4 RECENT DEVELOPMENTS 230 13.15 NIPR0 231 13.15.1 COMPANY SNAPSHOT 231 13.15.2 REVENUE ANALYSIS 231 13.15.3 PRODUCT PORTFOLIO 232 13.15.4 RECENT DEVELOPMENT 232 13.16 PFIZER INC 233 13.16.1 COMPANY SNAPSHOT 233 13.16.2 REVENUE ANALYSIS 233 13.16.3 PRODUCT PORTFOLIO 234 13.16.4 RECENT DEVELOPMENT 234 13.17 RECIPHARM AB. 235 13.17.1 COMPANY SNAPSHOT 235 13.17.2 REVENUE ANALYSIS 235 13.17.3 PRODUCT PORTFOLIO 236 13.17.4 RECENT DEVELOPMENT 236 13.18 SIEGFRIED HOLDING AG 237 13.18.1 COMPANY SNAPSHOT 237 13.18.2 REVENUE ANALYSIS 237 13.18.3 PRODUCT PORTFOLIO 238 13.18.4 RECENT DEVELOPMENTS 238 13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 239 13.19.1 COMPANY SNAPSHOT 239 13.19.2 REVENUE ANALYSIS 239 13.19.3 PRODUCT PORTFOLIO 240 13.19.4 RECENT DEVELOPMENT 240 13.20 TE CONNECTIVITY 241 13.20.1 COMPANY SNAPSHOT 241 13.20.2 REVENUE ANALYSIS 241 13.20.3 PRODUCT PORTFOLIO 242 13.20.4 RECENT DEVELOPMENT 242 13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 243 13.21.1 COMPANY SNAPSHOT 243 13.21.2 PRODUCT PORTFOLIO 243 13.21.3 RECENT DEVELOPMENTS 243 14 QUESTIONNAIRE 244 15 RELATED REPORTS 247 List of Tables/GraphsLIST OF TABLESTABLE 1 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59 TABLE 2 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 60 TABLE 3 ASIA PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61 TABLE 4 ASIA PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61 TABLE 5 ASIA PACIFIC BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62 TABLE 6 ASIA PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 63 TABLE 7 ASIA PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64 TABLE 8 ASIA PACIFIC MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 65 TABLE 9 ASIA PACIFIC CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 66 TABLE 10 ASIA PACIFIC TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67 TABLE 11 ASIA PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 69 TABLE 12 ASIA PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 70 TABLE 13 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 75 TABLE 14 ASIA PACIFIC PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76 TABLE 15 ASIA PACIFIC BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77 TABLE 16 ASIA PACIFIC BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77 TABLE 17 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 78 TABLE 18 ASIA PACIFIC ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79 TABLE 19 ASIA PACIFIC RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 79 TABLE 20 ASIA PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 83 TABLE 21 ASIA PACIFIC RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84 TABLE 22 ASIA PACIFIC DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 85 TABLE 23 ASIA PACIFIC OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 86 TABLE 24 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 92 TABLE 25 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92 TABLE 26 ASIA-PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93 TABLE 27 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93 TABLE 28 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT) 94 TABLE 29 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP) 94 TABLE 30 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 31 ASIA-PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 32 ASIA-PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 95 TABLE 33 ASIA-PACIFIC MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96 TABLE 34 ASIA-PACIFIC TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 96 TABLE 35 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 97 TABLE 36 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 98 TABLE 37 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99 TABLE 38 ASIA-PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99 TABLE 39 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 100 TABLE 40 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100 TABLE 41 JAPAN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 42 JAPAN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 43 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101 TABLE 44 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 102 TABLE 45 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 102 TABLE 46 JAPAN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 47 JAPAN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 48 JAPAN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 103 TABLE 49 JAPAN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104 TABLE 50 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 104 TABLE 51 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 105 TABLE 52 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 106 TABLE 53 JAPAN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107 TABLE 54 JAPAN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107 TABLE 55 JAPAN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 108 TABLE 56 JAPAN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108 TABLE 57 CHINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 58 CHINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 59 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109 TABLE 60 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 110 TABLE 61 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 110 TABLE 62 CHINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 63 CHINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 64 CHINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 111 TABLE 65 CHINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112 TABLE 66 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 112 TABLE 67 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 113 TABLE 68 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 114 TABLE 69 CHINA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115 TABLE 70 CHINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115 TABLE 71 CHINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 116 TABLE 72 CHINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 116 TABLE 73 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 74 SOUTH KOREA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 75 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117 TABLE 76 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 118 TABLE 77 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 118 TABLE 78 SOUTH KOREA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 79 SOUTH KOREA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 80 SOUTH KOREA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119 TABLE 81 SOUTH KOREA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120 TABLE 82 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120 TABLE 83 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 121 TABLE 84 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 122 TABLE 85 SOUTH KOREA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 122 TABLE 86 SOUTH KOREA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123 TABLE 87 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 123 TABLE 88 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 123 TABLE 89 INDIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 90 INDIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 91 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124 TABLE 92 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 125 TABLE 93 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 125 TABLE 94 INDIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 95 INDIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 96 INDIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126 TABLE 97 INDIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127 TABLE 98 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 127 TABLE 99 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 128 TABLE 100 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 129 TABLE 101 INDIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130 TABLE 102 INDIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130 TABLE 103 INDIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 131 TABLE 104 INDIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 131 TABLE 105 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 106 AUSTRALIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 107 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132 TABLE 108 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 133 TABLE 109 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 133 TABLE 110 AUSTRALIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 111 AUSTRALIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 112 AUSTRALIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134 TABLE 113 AUSTRALIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135 TABLE 114 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 135 TABLE 115 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 136 TABLE 116 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 137 TABLE 117 AUSTRALIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138 TABLE 118 AUSTRALIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138 TABLE 119 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 139 TABLE 120 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139 TABLE 121 SINGAPORE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 122 SINGAPORE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 123 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 140 TABLE 124 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 141 TABLE 125 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 141 TABLE 126 SINGAPORE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 127 SINGAPORE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 128 SINGAPORE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 142 TABLE 129 SINGAPORE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143 TABLE 130 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 143 TABLE 131 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 144 TABLE 132 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 145 TABLE 133 SINGAPORE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146 TABLE 134 SINGAPORE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 146 TABLE 135 SINGAPORE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 147 TABLE 136 SINGAPORE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147 TABLE 137 THAILAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 138 THAILAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 139 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148 TABLE 140 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 149 TABLE 141 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 149 TABLE 142 THAILAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 143 THAILAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 144 THAILAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 150 TABLE 145 THAILAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151 TABLE 146 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 151 TABLE 147 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 152 TABLE 148 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 153 TABLE 149 THAILAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154 TABLE 150 THAILAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 154 TABLE 151 THAILAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 155 TABLE 152 THAILAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 155 TABLE 153 MALAYSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 154 MALAYSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 155 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156 TABLE 156 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 157 TABLE 157 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 157 TABLE 158 MALAYSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 159 MALAYSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 160 MALAYSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 158 TABLE 161 MALAYSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159 TABLE 162 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 159 TABLE 163 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 160 TABLE 164 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 161 TABLE 165 MALAYSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162 TABLE 166 MALAYSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 162 TABLE 167 MALAYSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 163 TABLE 168 MALAYSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163 TABLE 169 INDONESIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 170 INDONESIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 171 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 164 TABLE 172 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 165 TABLE 173 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 165
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
Data Bridge Market Research社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(apac)の最新刊レポート
よくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |